13th May 2021
Virtual Conference
9:00
Opening Remarks
Ray Cahill
Chair, HealthTech Ireland and Territory Vice President International, Change Healthcare
9:10
Welcome from the Chair
Pat O’Mahony
Chair, HIQA; CEO, Mapat Management Consultants and former Deputy Secretary General, Department of Health
9:15
GOVERNMENT ADDRESS:
INNOVATION – New partnerships, collaborations and co-operative models
9:25
MORNING KEYNOTE ADDRESS:
A model for spreading and scaling innovation throughout the healthcare system
The Academic Health Science Network (AHSN) model for spreading innovation has attracted international attention. In this session we will hear about this approach to supporting the scaling up of innovation and the lessons we can learn.
Mike Burrows
National Coordination Director, AHSN Network, UK
9:45
CASE STUDY:
How Intelligent Automation is changing healthcare
Vital-Signs Automation and Workflow Support at point-of care in hospital wards has been shown, in other countries, to deliver much-improved resource utilisation, more accurate and timely compliance with complex care protocols and improved patient outcomes. Now, as the HSE embraces digital transformation, what is the potential and what are the challenges?
David Toohey
C.Eng, FIEI, MBA, CEO, Syncrophi Systems
10:05
PANEL DISCUSSION:
What new partnerships, innovation and collaboration models are developing in Ireland?
Dr. Brendan Boland
CEO, Loci Orthopaedics
Dr. Tanya Mulcahy
Interim Director, Health Innovation Hub Ireland (HIHI)
Fiona Campbell
Clinical Industry liaison Officer, Health Research Board Clinical Research Coordination Ireland (HRB CRCI)
John Kelly
Deputy CEO, Tallaght University Hospital
10:40
Networking break
Removing barriers to innovation and overcoming the commercial challenges
10:50
The future of innovation post Covid-19 – Commercial challenges facing Irish industry
Innovation is a key component of sustainable, accessible and equitable healthcare. The COVID-19 crisis demonstrated how Irish Health Tech companies supported by Enterprise Ireland are global leaders in innovation. A 2020 OECD report ranks Ireland among the top countries in the world for producing innovative solutions to the current Covid-19 crisis. As companies continue to adapt, innovate and create new healthcare solutions, how can we address some of the existing commercial barriers and streamline the process of bringing innovative products and services to market rapidly?
Deirdre Glenn
Head of Lifesciences, Enterprise Ireland
11:10
CASE STUDY:
Scaling innovation
Vitalograph design, manufacture, sell and service a wide range of cardio- respiratory screening, diagnostic and monitoring devices for use within primary, secondary and tertiary care and also within the occupational health arena. Frank shares how he expanded and scaled up his business and the pitfalls he overcame along the way.
Frank Keane
CEO, Vitalograph Group
11:25
PANEL DISCUSSION:
A fundamental truth: The commercial challenges facing healthtech scale-ups
Innovation in medical technology has never been so promising; we must think big and work collaboratively to support innovative ventures that have long-term potential. To do so we must continue to provide clear access to both funding and training, to help tomorrow’s healthtech leaders achieve ambitious growth. Our panel of entrepreneurs share their experience and insights on commercialising innovation for the Irish health system.
Sonia Neary
CEO and Co-founder, Wellola
David Clancy
Chief Technology Officer, Serosep Ireland Ltd.
John O’Dea
Group Chief Executive Officer, Palliare
12:00
Lunch
12:30
Welcome back from the Chair
Pat O’Mahony
Chair HIQA, CEO Mapat Management Consultants and former Deputy Secretary General, Department of Health
EVALUATION – new ways of showing the value health tech can bring?
12:35
The regulatory perspective and overview of new EU regulations on Health Technology Assessment
Dr. Patricia Harrington
Head of Assessment, Health Technology Assessment, HIQA
12:50
Putting patient benefits at the centre of healthcare purchasing decisions
- How is Value Based Procurement evolving?
- VBP in practice: Examples of how value-based agreements are innovating healthcare delivery across the EU
- Plus, practical insights on how to get started on the transition from transactional relationships towards value-based partnerships between healthcare providers and suppliers.
Goetz Gerecke
Managing Director and Senior Partner, the Boston Consulting Group, Switzerland
1:10
PANEL DISCUSSION:
The latest thinking on evaluating new technologies for healthcare
– Evaluating medical technologies using qualitative measures
– Changing the way the health service evaluates goods and services
– Moving from transactional relationships towards value-based partnerships
Martin Curley
Director, Digital Transformation and Open Innovation, HSE
Jim Joyce
Founder and CEO, HealthBeacon
Jim Dowdall
Strategic Advisor and former Managing Director, Irish Life Health
Tying it all together & making it happen
1:45
Networking break
1:55
INTERNATIONAL KEYNOTE ADDRESS:
How a US healthcare group is focused on innovation and trying new technologies
Chris Coburn
Chief Innovation Officer, at Mass General Brigham, USA
2:15
CASE STUDY:
Integrating research and innovation centres on St James’s Hospital Campus
CEO Mary Day outlines her strategic ambition for St James’s Hospital Campus to evolve into an Integrated Academic Health Science Campus which will deliver improved healthcare outcomes for patients and create the most dynamic healthcare campus nationally and in Europe.
Mary Day
Chief Executive, St. James's Hospital
2:35
PANEL DISCUSSION:
Collaborating and co-operating for successful innovation in Irish healthcare
Alan Brace
Director of Finance, Health and Social Services Group, Welsh Government
Eilísh Hardiman
Chief Executive, Children’s Healthcare Ireland
Michelle Sullivan
Senior Manager HEMA, UK & Ireland, Boston Scientific